Brought to you by:
Search Results for abdominal aortic aneurysm
‘Critical’ importance of lifelong surveillance after EVAR headlines newly published 10-year ENGAGE data
Ten-year data highlight the long-term efficacy and durability of the Endurant stent graft (Medtronic) in abdominal aortic aneurysm (AAA) patients who survived beyond five years post-enrollment in the ENGAGE registry. However, researchers also draw attention to the incidence of late…
Danish study suggests patients with AAA could benefit from high-dose statin use
A five-year prospective cohort study—using longitudinal registry data from two population-based screening trials—has found that high-dose statin use was associated with decreased abdominal aortic aneurysm (AAA) growth rates and lowered risk of undergoing repair, rupture, and death. Researchers therefore suggest…
Cook announces US launch of Zenith iliac branch device
Cook Medical has announced that its Zenith iliac branch device (ZBIS) is now commercially available in the U.S. with Food and Drug Administration (FDA) approval as an endovascular treatment option for aortoiliac or iliac aneurysmal disease. The company has also…
Researchers examine safety of prophylactic spinal fluid drainage in open and endovascular TAA and TAAA patients
“Spinal fluid drainage be considered when the risk of spinal cord injury from the procedure is greater than the risk of severe complications from spinal fluid drainage.” This was one of the concluding findings of a study presented during the…
Increased experience with off-the-shelf TAAA endograft sees reduction in complications but no effect on mortality
Michele Piazza, MD, informed attendees of the 2025 Vascular Annual Meeting (VAM) that increased experience with the E-nside (Artivion) off-the-shelf preloaded inner branch endograft for branched endovascular aneurysm repair (BEVAR) leads to a “significant” reduction in intraprocedural complications, but does not…
One-year TAMBE data highlight low mortality, importance of renal branch assessment
The four-branch Gore Excluder thoracoabdominal branch endoprosthesis (TAMBE) device demonstrated low mortality at one year with renal artery occlusion being the predominant device-related event associated with small renal arteries and pararenal aneurysms. So concluded Mark A. Farber, MD, presenting the…
Training smarter, not harder: Analysis finds no negative impact of reduced core surgical requirements
Since the 2018 Accreditation Council for Graduate Medical Education (ACGME) reduction of core surgical requirements from 24 to 18 months during integrated vascular surgery residency, vascular residents’ operative experience has been unaffected, suggesting improved training optimization and efficiency. This was…
The Survivalist’s Guide to Heart and Vascular Centers
Malachi Sheahan III, MD, produces notes on a quixotic quest to find meaning in one of medicine’s most meaningless endeavors. Here’s how it happens. One day, you are walking through your hospital, and you notice a pack of incongruously well-dressed…
Reality check: Study brings ‘significant’ gap between randomized and real-world vascular patient populations into sharp focus
The randomized data foundation on which clinicians base decision-making for vascular surgery patients is derived from populations that do not represent the patients they see and treat on a day-to-day basis, a new research paper has found. The review, recently…
From Olympic triumph to healthcare advocacy: Jim Craig to deliver VAM 2025 keynote address
Jim Craig, a longtime support and vascular advocate, will deliver the annual keynote address at the 2025 Vascular Annual Meeting (VAM) in New Orleans (June 4–7). Craig is known as the goaltender for the 1980 U.S. Olympic hockey team and…